Get the Sample Copy (Including FULL TOC, Graphs, and Tables) of this report @: https://www.worldwidemarketreports.com/sample/872073 The Recombinant Glycosylated Proteins Biosimilar offers the market perspective by giving its clients precise data that…

A concise assortment of data on the Biosimilar Monoclonal Antibodies Market offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market…

31 January 2023 Goodwin Procter LLP To print this article, all you need is to be registered or login on Mondaq.com. Last week, Celltrion filed an…

January 30, 2023 1 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when…

Celltrion said on Friday that it won the first trial of two patents (Patent No. US 9254338, US 9669069) against Regeneron, a leading biotechnology company in the United…

The Global Herceptin Biosimilar Market Size was valued at USD 1,795 Million in 2021 and is predicted to be worth USD 11,287 Million by 2030, with a CAGR of 23.2%…

Kim Jin-yong, commissioner of the Incheon Free Economic Zone Authority The Incheon Free Economic Zone (IFEZ) used to be an island, sea, tidal flat, and reclaimed land, but…

Pune, India, Jan. 27, 2023 (GLOBE NEWSWIRE) — The global Point of Care Diagnostics Market size was valued at USD 46.65 billion in 2021. It is estimated to rise from…

Cho Won-kyung The author is head of the Global Academy-Industry Cooperation Center at the Ulsan National Institute of Science and Technology.Expectations for the Korean bio industry were high after the…

Last week, Celltrion filed an IPR petition, PTAB IPR2023-00462, seeking cancellation of claims 1-18 of U.S. Patent No. 10,464,992 (“the ’992 patent”), assigned to Regeneron Pharmaceuticals, Inc.  According to the…